Up Front

• Renewed Purpose for Some Drugs
  CHI's Drug Repositioning Summit found new tricks for old compounds.
• Sequenom's Eye on the Future
  CSO Charles Cantor on the prospects for nanopore technology.
• Bio-IT World Expo 2008 Keynote Speakers
  Avey, Boger, and Reynders head sixth annual Expo.
• OSINT and the Pharmaceutical Enterprise
  INSIGHTS | OUTLOOK - Open-source tools are needed in biopharma.
  By James Golden
• Sunny Skies for Compute Cloud
  INSIDE THE BOX - Cloud computing at Amazon provides power at the right price.
  By Michael Cariaso
• Back to Omics
  THE BIOMARKER REPORT - Novel approaches and tools open new windows.
  By Malorye Allison
• News Briefs 

• Sunlight and Systems Biology in Seattle
  ISB course whets appetites and spurs projects.
• Surviving the New Patent Regime
  New USPTO rules limit patent rights and complicate process. 

Computational Development

• ABCD: The Relentless Pursuit of Perfection
  Johnson & Johnson's IT team built it, and they came.
• 'Cross-Omics' and Systems Toxicology
  Systems approaches combine toxicogenomics data with toxicological endpoints.

 IT/Workflow

• Microsoft's Move into Life Sciences
  Rudy Potenzone discusses new plans and the BioIT Alliance.
• Of Data Silos and Sacred Cows
  CHI's Bridging Pharma & IT conference shares winning informatics strategies that span the drug discovery pipeline.

Clinical Research

• Help Desk: A Critical Function
  The clinical trial help desk is essential to global studies.
• The Changing Roles for Telemedicine
  In addition to patient monitoring, telemedicine adds patient recruitment to the list.

In Every Issue

• Can Academics Save Pharma?
  FIRST BASE - Big pharma turns to academia to invigorate starving pipelines.
  By Kevin Davies
• Improving Structure Prediction
  THE RUSSELL TRANSCRIPT - Baker-led group advances protein structure software.
  By John Russell
• New Products